Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 75296001 |
Registration Number | 2455635 |
Mark Drawing Code | 3R21: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Domestic Representative | JEFFREY H KAUFMAN |
Attorney Name | JEFFREY H KAUFMAN |
Attorney Docket Number | 168862US |
Law Office Assigned | M10 |
Employee Name | WOOD, CAROLINE |
1997-05-22 | Application Filed |
1999-09-21 | Date of First Use |
2000-02-01 | Published for Opposition |
2001-05-29 | Trademark Registered |
2011-05-11 | Location: GENERIC WEB UPDATE |
2011-05-11 | Status: Live/Registered |
2011-05-29 | Renewal Date |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Address | No.2-5, Nishishinjuku 3-chome Shinjuku-ku, Tokyo JP |
Legal Entity Type | Corporation |
Legal Entity State | JP |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
191325 | Beakers |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | medicines for human purposes, namely, pharmaceutical preparations for the treatment of the central nervous system, peripheral nervous system, sensory organs, [ allergies, circulatory organs, respiratory organs, digestive organs, urogenital organs or anus, blood, tumors, physical disorders, chemical disorders, parasites; hormones; dermatological medicines; vitamins; dietary supplements in the nature of amino acids; food supplements; medicinal tonics to heal, cleanse, energize and strengthen the body; metabolic medicines; ] antibiotics [ ; pharmaceutical preparations for use in the activation of cells and in chemotherapy; biological medicines, namely, vaccines, nutritional supplements for the stimulation of defensive mechanisms against toxins and toxoids and for the elimination of toxins and toxoids, antitoxins and anti-leptospira serums used for counteracting drugs or other toxic substances for use in poisonings and drug overdoses, and tetanus antitoxins, medical diagnostic reagents used in biological examination; pharmaceutical preparations for use in inducing narcosis; pharmaceutical preparations for use in diagnosis; namely, contrast media for radiography, reagents for function tests, general examination, hematological examination, blood chemistry examination, immuno-serological examination, bacteriological examination, histopathological examination, and radiopharmaceuticals for extrasomatic diagnosis ] |
Description | Date | Event Coding |
---|---|---|
ASSIGNED TO EXAMINER | 1997-12-19 | 1 DOCK D:Assigned to Examiner |
NON-FINAL ACTION MAILED | 1997-12-23 | 2 CNRT F:First Action |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1998-06-25 | 3 CRFA I:Incoming Correspondence |
NON-FINAL ACTION MAILED | 1998-08-05 | 4 CNRT F:First Action |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-02-24 | 5 CRFA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-02-24 | 6 CRFA I:Incoming Correspondence |
FINAL REFUSAL MAILED | 1999-04-20 | 7 CNFR O:Outgoing Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-09-30 | 8 CRFA I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 1999-11-29 | 9 CNSA P: |
NOTICE OF PUBLICATION | 1999-12-30 | 10 NPUB O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2000-02-01 | 11 PUBO A:Allowance for Publication |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2000-04-25 | 12 NOAM O:Outgoing Correspondence |
EXTENSION 1 FILED | 2000-10-03 | 13 EXT1 S: |
EXTENSION 1 GRANTED | 2000-10-03 | 14 EX1G S: |
USE AMENDMENT FILED | 2000-10-03 | 15 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2000-10-03 | 16 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2001-03-04 | 17 CNPR P: |
REGISTERED-PRINCIPAL REGISTER | 2001-05-29 | 18 R.PR A:Allowance for Publication |
CASE FILE IN TICRS | 2006-10-20 | 19 CFIT O:Outgoing Correspondence |
PAPER RECEIVED | 2007-03-13 | 20 MAIL I:Incoming Correspondence |
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2007-03-13 | 21 815F I:Incoming Correspondence |
ASSIGNED TO PARALEGAL | 2007-04-10 | 22 PLGL A:Allowance for Publication |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2007-04-16 | 23 C15A O:Outgoing Correspondence |
TEAS SECTION 8 & 9 RECEIVED | 2011-04-22 | 24 E89R I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2011-05-11 | 25 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2011-05-11 | 26 89AG O:Outgoing Correspondence |
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2011-05-11 | 27 RNL1 Q: |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2015-01-20 | 28 TCCA I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2020-05-29 | 29 REM2 E:E-Mail |
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2021-12-03 | 30 CAEX O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.